Human Nutrition & Health was Balchem’s largest segment in fiscal 2025, bringing in $659.39M of $1.04B (64%).
| Segment | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Human Nutrition & Health | — | $550.75M | $600.26M | $659.39M | ||||||||||||
| Hnh | $527.13M | — | — | — | ||||||||||||
| A Reportable Segment Of The Company That Provides The Human, Nutrition & Health Markets With Products Derived From Its Micro Capsulation, Chelation And Basic Choline Chloride Technologies | — | — | — | — | ||||||||||||
| A Reportable Segment Of The Company That Provides The Human Nutrition & Health For Use In Healthcare & Other Industries | — | — | — | — | ||||||||||||
| Animal Nutrition & Health | — | $238.33M | $214.71M | $230.85M | ||||||||||||
| Anh | $262.30M | — | — | — | ||||||||||||
| A Reportable Segment Of The Company That Provides The Animal, Nutrition & Health Markets With Products Derived From Its Micro Capsulation, Chelation And Basic Choline Chloride Technologies | — | — | — | — | ||||||||||||
| A Reportable Segment Of The Company That Provides The Animal, Nutrition & Health Markets With Products Derived From Its Microcapsulation, Chelation And Basic Choline Chloride Technologies | — | — | — | — | ||||||||||||
| Specialty Products | $131.44M | $125.97M | $132.75M | $140.98M | ||||||||||||
| A Reportable Segment Of The Company That Provides Specialty-Packaged Chemicals For Use In Healthcare & Other Industries | — | — | — | — | ||||||||||||
| Industrial Products | — | — | — | — | ||||||||||||
| A Reportable Segment Of The Company That Provides Certain Derivatives Of Industrial Applications Predominately As A Component For Hydraulic Fracturing Of Shale Natural Gas Wells | — | — | — | — | ||||||||||||
| A Reportable Segment Of The Company That Provides The Sensory Effects For Use In Healthcare & Other Industries | — | — | — | — | ||||||||||||
| A Reportable Segment Of The Company That Provides Microencapsulation Solutions To A Variety Of Applications In Food, Pharmaceutical & Nutritional Ingredients To Enhance Performance Of Nutritional Fortification, Processing, Mixing, Packaging Applications And Shelf-Life | — | — | — | — | ||||||||||||
| Other & Unallocated | $21.49M | $7.40M | $5.97M | $5.95M | ||||||||||||
| Total | $942.36M | $922.44M | $953.68M | $1.04B |
Balchem brought in $1.04B from its four segments in fiscal 2025, the year ended December 31, 2025. That was up 8.8% from $953.68M in fiscal 2024. Human Nutrition & Health was the largest at $659.39M (63.6%), ahead of Animal Nutrition & Health at $230.85M (22.3%) and Specialty Products at $140.98M (13.6%). The remaining segment, Other & Unallocated, brought in $5.95M.
Compared with fiscal 2024, Human Nutrition & Health grew fastest, up 9.9% to $659.39M. Every segment above 2% of revenue grew.
Balchem stopped reporting Hnh ($527.13M in fiscal 2022) and Anh ($262.30M in fiscal 2022) as separate segments.
Product Sales Revenue was Balchem’s largest product and service line in fiscal 2025, bringing in $1.04B of $1.04B (100%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Product Sales Revenue | $939.17M | $919.95M | $951.95M | $1.04B | ||||||
| Product Sales | — | — | — | — | ||||||
| Co-Manufacturing | — | — | — | — | ||||||
| Royalty Revenue | $3.19M | $2.49M | $1.74M | $1.89M | ||||||
| Bill & Hold | — | — | — | — | ||||||
| Consignment | — | — | — | — | ||||||
| Total | $942.36M | $922.44M | $953.68M | $1.04B |
Balchem brought in $1.04B from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 8.8% from $953.68M in fiscal 2024. Product Sales Revenue was the largest at $1.04B (99.8%), ahead of Royalty Revenue at $1.89M (0.2%).
From fiscal 2022 to 2025, combined revenue from these lines grew from $942.36M to $1.04B, a compound annual growth rate of 3.2%. Product Sales Revenue's share held steady at about 99.8%.
United States was Balchem’s largest region in fiscal 2025, bringing in $759.45M of $1.04B (73%).
| Geography | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $682.24M | $689.60M | $723.30M | $759.45M | ||||||||||||
| Foreign Countries | $260.12M | $232.84M | $230.38M | $277.71M | ||||||||||||
| Net Sales | — | — | — | — | ||||||||||||
| Refers To Revenues From External Customers Attributed To All Foreign Countries In Total From Which The Entity Derives Revenues | — | — | — | — | ||||||||||||
| Total | $942.36M | $922.44M | $953.68M | $1.04B |
Balchem brought in $1.04B from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 8.8% from $953.68M in fiscal 2024. United States was the largest at $759.45M (73.2%), ahead of Foreign Countries at $277.71M (26.8%).
Compared with fiscal 2024, Foreign Countries grew 20.5% to $277.71M and United States grew 5.0% to $759.45M. From fiscal 2022 to 2025, combined revenue from these regions grew from $942.36M to $1.04B, a compound annual growth rate of 3.2%. United States' share of the total rose from 72.4% to 73.2%.
Balchem (BCPC) reports its revenue by segment, by product and service and by geography. In fiscal 2025, Human Nutrition & Health was its largest segment, bringing in $659.39M (63.6% of the total), followed by Animal Nutrition & Health at $230.85M (22.3%).
Human Nutrition & Health was Balchem's largest segment in fiscal 2025, bringing in $659.39M, or 63.6% of the $1.04B total across its four segments.
Product Sales Revenue was Balchem's largest product and service line in fiscal 2025, bringing in $1.04B, or 99.8% of the $1.04B total across its two product and service lines.
United States was Balchem's largest region in fiscal 2025, bringing in $759.45M, or 73.2% of the $1.04B total across its two regions.
Among Balchem's segments that make up at least 2% of revenue, Human Nutrition & Health grew fastest in fiscal 2025, up 9.9% from $600.26M to $659.39M.
Every figure comes from Balchem's annual financial filings, as reported. Each line keeps the name Balchem gives it, and years follow its fiscal calendar.
Balchem's revenue by segment goes back to fiscal 2010, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.